Induction of CD8+ T cells using heterologous prime-boost immunisation strategies. by Schneider, J, Gilbert, S, Hannan, C, Dégano, P, Prieur, E, Sheu, E, Plebanski, M, Hill, A

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses. by Prieur, E, Gilbert, S, Schneider, J, Moore, A, Sheu, E, Goonetilleke, N, Robson, K, Hill, A

High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure by Tyagi, R, Gleeson, P, Arnold, L, Tahar, R, Prieur, E, Decosterd, L, Pérignon, J, Olliaro, P, Druilhe, P

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine. by Porter, D, Thompson, F, Berthoud, T, Hutchings, C, Andrews, L, Biswas, S, Poulton, I, Prieur, E, Correa, S, Rowland, R, Lang, T, Williams, J, Gilbert, S, Sinden, R, Todryk, S, Hill, A

A human phase I/IIa malaria challenge trial of a polyprotein malaria vaccine by Porter, D, Thompson, F, Berthoud, T, Hutchings, C, Andrews, L, Biswas, S, Poulton, I, Prieur, E, Correa, S, Rowland, R, Lang, T, Williams, J, Gilbert, S, Sinden, R, Todryk, S, Hill, A

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy. by Hill, A, Reece, W, Gothard, P, Moorthy, V, Roberts, M, Flanagan, K, Plebanski, M, Hannan, C, Hu, J, Anderson, R, Degano, P, Schneider, J, Prieur, E, Sheu, E, Gilbert, S